Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
about
Interventional sialendoscopy for radioiodine-induced sialadenitis: quo vadis?Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and DosimetryEffects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy.Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients.Paradoxes in thyroid carcinoma treatment: analysis of the SEER database 2010-2013.Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients.Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.Protective/restorative Role of the Adipose Tissue-derived Mesenchymal Stem Cells on the Radioiodine-induced Salivary Gland Damage in Rats.A Randomized Controlled Trial for the Effectiveness of Aromatherapy in Decreasing Salivary Gland Damage following Radioactive Iodine Therapy for Differentiated Thyroid Cancer.A Functional Scoring System Based on Salivary Gland Scintigraphy for Evaluating Salivary Gland Dysfunction Secondary to 131I therapy in Patients with Differentiated Thyroid Carcinoma.Development of an athyroid mouse model using 131I ablation after preparation with a low-iodine diet.Aging-Related Disease Risks among Young Thyroid Cancer Survivors.Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force.Sialendoscopy for non‐stone disorders: The current evidence.Sialendoscopy in the Management of Radioiodine Induced Sialadenitis: A Systematic Review.Sialendoscopy for non-stone disorders: The current evidence.Computed tomography features of the major salivary glands after radioactive iodine ablation in patients with papillary thyroid carcinoma.Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma.Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131 I-NaI treatments of differentiated thyroid cancer.Radioactive iodine: An unappreciated threat to salivary gland function.The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates.
P2860
Q33777034-EAD10E5E-04FA-4AD8-BDE1-B55A7BCB0082Q33802694-2F31A333-FB4A-41C6-979B-D34FE2954DB6Q33833660-917EFE3F-3BDD-42EE-A8E1-210DC8984D74Q34712784-55D34884-941D-4C43-A247-723B2DB5E34DQ35750722-EC5A98F3-6DF1-406B-B188-9E3153075392Q36542104-AA26DC31-005E-461D-BD52-DB7B39804356Q37702230-A3A9FE47-F636-42FE-A170-FD5843A3955DQ39204422-23F6AAB2-4A1A-41F8-91F5-ED713634AA99Q40492966-D6CC011C-A481-4746-BEFB-03426A8123BFQ40676597-BFC30E2A-A71E-40FA-B801-9558EF7A112CQ41678143-7D4F70D9-D759-416A-87A0-76C553EBEE3BQ42353221-E69CA123-723B-4068-A6F9-AD9DFD6E506CQ42367086-CE04B559-B805-45EE-839C-3F42B0960588Q42378831-FADF669F-A3D8-46A1-93E3-AFA0EFE89189Q46799892-0B78C09B-7C0C-477A-8D16-3976CB687C17Q47105571-23A39D3A-5B70-432C-896F-790CBCB9CD7BQ47165344-314E27B1-AE87-44A7-A158-BB10F54CD59DQ47920505-B2964C57-4D64-44E9-A2EE-0A583330535FQ47999470-4E9E6CEB-13E0-4831-B33C-5E59E2FC9A72Q48317609-06DAC310-878E-4554-82C4-36BD570D4D35Q50067205-E36C96F3-5320-4D82-ACE4-68DEF5AF6EB3Q50943856-780D3E34-3841-4253-B13A-B67432C7E256Q51747725-CE3D73F8-6A6C-43AD-BC6E-1B837400E34AQ53578187-E4C8EB09-4B82-488A-B62F-89595F207BAA
P2860
Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Salivary gland function 5 year ...... lation to xerostomia symptoms.
@ast
Salivary gland function 5 year ...... lation to xerostomia symptoms.
@en
type
label
Salivary gland function 5 year ...... lation to xerostomia symptoms.
@ast
Salivary gland function 5 year ...... lation to xerostomia symptoms.
@en
prefLabel
Salivary gland function 5 year ...... lation to xerostomia symptoms.
@ast
Salivary gland function 5 year ...... lation to xerostomia symptoms.
@en
P2093
P2860
P356
P1433
P1476
Salivary gland function 5 year ...... lation to xerostomia symptoms.
@en
P2093
Byeong-Cheol Ahn
Hae Won Kim
Jaetae Lee
Sang-Woo Lee
Shin Young Jeong
P2860
P304
P356
10.1089/THY.2012.0106
P577
2013-04-18T00:00:00Z